journal
Journals European Journal of Pharmaceut...

European Journal of Pharmaceutical Sciences

https://read.qxmd.com/read/38615970/curcumin-and-quercetin-co-encapsulated-in-nanoemulsions-for-nasal-administration-a-promising-therapeutic-and-prophylactic-treatment-for-viral-respiratory-infections
#21
JOURNAL ARTICLE
Daniela Pastorim Vaiss, Jamile Lima Rodrigues, Virginia Campello Yurgel, Frank do Carmo Guedes, Lauanda Larissa Mendonça da Matta, Paula Alice Bezerra Barros, Gustavo Richter Vaz, Raíssa Nunes Dos Santos, Bibiana Franzen Matte, Larine Kupski, Jaqueline Garda-Buffon, Juliana Bidone, Ana Luiza Muccillo-Baisch, Fabio Sonvico, Cristiana Lima Dora
One of the most frequent causes of respiratory infections are viruses. Viruses reaching the airways can be absorbed by the human body through the respiratory mucosa and mainly infect lung cells. Several viral infections are not yet curable, such as coronavirus-2 (SARS-CoV-2). Furthermore, the side effect of synthetic antiviral drugs and reduced efficacy against resistant variants have reinforced the search for alternative and effective treatment options, such as plant-derived antiviral molecules. Curcumin (CUR) and quercetin (QUE) are two natural compounds that have been widely studied for their health benefits, such as antiviral and anti-inflammatory activity...
April 12, 2024: European Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/38614153/cubic-liquid-crystals-containing-propolis-flavonoids-as-in-situ-thermo-sensitive-hydrogel-depots-for-periodontitis-treatment-preparation-pharmacodynamics-and-therapeutic-mechanisms
#22
JOURNAL ARTICLE
Maomao Tang, Jiaxin Li, Guichun Wang, Yuxiao Wang, Chengjun Peng, Xiangwei Chang, Yaotian Tao, Jian Guo, Shuangying Gui
Propolis has a long ethnopharmacological history for oral periodontal diseases treatment. Propolis flavonoids are main active components for anti-inflammation and tissue protection. However, the intractable dissolution properties of propolis flavonoids and complex oral environment pose great challenges for periodontal delivery. In addition, the therapeutic mechanism as well as the therapeutic correlation of inflammation resolution and tissue regeneration remain unclear for propolis flavonoids. In this study, we constructed an in situ thermosensitive depot systems using total flavonoids from propolis-loaded cubic liquid crystals (TFP-CLC) hydrogel for periodontal delivery...
April 11, 2024: European Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/38608735/absorption-of-cinnarizine-from-type-ii-lipid-based-formulations-impact-of-lipid-chain-length-supersaturation-digestion-and-precipitation-inhibition
#23
JOURNAL ARTICLE
Felix Paulus, René Holm, Jef Stappaerts, Annette Bauer-Brandl
Lipid-based formulations (LBFs) are an enabling-formulation approach for lipophilic poorly water-soluble compounds. In LBFs, drugs are commonly pre-dissolved in lipids, and/or surfactants/cosolvents, hereby avoiding the rate-limiting dissolution step. According to the Lipid formulation classification system, proposed by Pouton in 2006, in type II LBFs a surfactant with an HLB-value lower than 12 is added to the lipids. If high drug doses are required, e.g. for preclinical toxicity studies, supersaturated LBFs prepared at elevated temperatures may be a possibility to increase drug exposure...
April 10, 2024: European Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/38599506/first-in-human-study-on-pharmacokinetics-safety-and-tolerability-of-single-and-multiple-escalating-doses-of-pa9159-nasal-spray-a-highly-potent-glucocorticoid-in-healthy-chinese-volunteers
#24
JOURNAL ARTICLE
Shaojie Guo, Yingchun Hu, Chengshuo Wang, Yuan Zhang, Feng Wu, Siyang Ni, Yuyang Dai, Ying Han, Minwan Hu, Chunping Lu, Zhijian Xi, Laichun Lu, Xiuli Zhao, Luo Zhang
OBJECTIVE: PA9159 (previously named VSG159) is a structurally novel and highly potent glucocorticoid that plays a role in the late development of autoimmune and inflammatory diseases. The current first-in-human ascending-dose study of the PA9159 nasal spray was conducted in healthy Chinese volunteers to evaluate its pharmacokinetics, safety, and tolerability. In addition, the effects of PA9159 on serum cortisol secretion were investigated. METHODS: This was a double-blinded, randomized, placebo-controlled clinical study that included four single-dose groups in the single ascending dose cohort (SAD) and two multiple-dose groups in the multiple ascending dose cohort (MAD), with dose ranges of 10-80 μg and 20-40 μg, respectively...
April 8, 2024: European Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/38599505/model-informed-drug-development-hsk21542-pbpk-model-supporting-dose-decisions-in-specific-populations
#25
JOURNAL ARTICLE
Miao Zhang, Zihan Lei, Xueting Yao, Lei Zhang, Pangke Yan, Nan Wu, Meixia Chen, Fengyi Zhang, Dongyang Liu
HKS21542, a highly selective activator of peripheral kappa opioid receptor agonists, plays a critical role in antinociception and itch inhibition during clinical development. Due to its indication population and elimination characteristics, it is imperative to evaluate the potential HSK21542 systemic exposure in individuals with renal impairment, hepatic impairment, the elderly, and the geriatric population. Here, a physiologically-based pharmacokinetic (PBPK) model for HSK21542 was developed based on in vitro metabolism and transport characteristics and in vivo elimination mechanism...
April 8, 2024: European Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/38580169/unveiling-the-potential-of-biomaterials-and-their-synergistic-fusion-in-tissue-engineering
#26
REVIEW
Eva Sanchez Armengol, Nathalie Hock, Sila Saribal, Dennis To, Simona Summonte, Florina Veider, Gergely Kali, Andreas Bernkop-Schnürch, Flavia Laffleur
Inspired by nature, tissue engineering aims to employ intricate mechanisms for advanced clinical interventions, unlocking inherent biological potential and propelling medical breakthroughs. Therefore, medical, and pharmaceutical fields are growing interest in tissue and organ replacement, repair, and regeneration by this technology. Three primary mechanisms are currently used in tissue engineering: transplantation of cells (I), injection of growth factors (II) and cellular seeding in scaffolds (III). However, to develop scaffolds presenting highest potential, reinforcement with polymeric materials is growing interest...
April 3, 2024: European Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/38574899/ex-vivo-gut-hepato-biliary-organ-perfusion-model-to-characterize-oral-absorption-gut-wall-metabolism-pre-systemic-hepatic-metabolism-and-biliary-excretion-application-to-midazolam
#27
JOURNAL ARTICLE
L J Stevens, E van de Steeg, J B Doppenberg, I P J Alwayn, C A J Knibbe, J Dubbeld
To date, characterization of the first-pass effect of orally administered drugs consisting of local intestinal absorption and metabolism, portal vein transport and hepatobiliary processes remains challenging. Aim of this study was to explore the applicability of a porcine ex-vivo perfusion model to study oral absorption, gut-hepatobiliary metabolism and biliary excretion of midazolam. Slaughterhouse procured porcine en bloc organs (n=4), were perfused via the aorta and portal vein. After 120min of perfusion, midazolam, atenolol, antipyrine and FD4 were dosed via the duodenum and samples were taken from the systemic- and portal vein perfusate, intestinal faecal effluent and bile to determine drug and metabolite concentrations...
April 2, 2024: European Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/38570054/vitamin-d-loaded-into-lipid-nanoparticles-shows-insulinotropic-effect-in-ins-1e-cells
#28
JOURNAL ARTICLE
Cecília Cristelo, Ana Filipa Sá, Marlene Lúcio, Bruno Sarmento, Francisco Miguel Gama
Increasing evidence suggests a beneficial role of vitamin D (VitD) supplementation in addressing the widespread VitD deficiency, but currently used VitD3 formulations present low bioavailability and toxicity constrains. Hence, poly(L-lactide-co-glycolide) (PLGA) nanoparticles (NPs), solid-lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) were investigated to circumvent these issues. PLGA NPs prepared by emulsification or nanoprecipitation presented 74 or 200 nm, and association efficiency (AE) of 68 % and 17 %, respectively, and a rapid burst release of VitD3...
April 1, 2024: European Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/38570053/xuebijing-injection-and-its-bioactive-components-alleviate-nephrotic-syndrome-by-inhibiting-podocyte-inflammatory-injury
#29
JOURNAL ARTICLE
Shengliang Yuan, Yiwen Cao, Jiaying Jiang, Junqi Chen, Xiuye Huang, Xiaojie Li, Jie Zhou, Yuan Zhou, Jiuyao Zhou
Xuebijing injection (XBJ) is widely used to treat nephrotic syndrome (NS) in clinic, but its bioactive components and therapeutic mechanism are still unclear. In this study, the bioactive components of XBJ were determined by ultra-performance liquid chromatography quadrupole time-of-flight tandem mass spectrometry (UPLC-Q-TOF/MS). The therapeutic effect of XBJ on NS was evaluated in BALB/c mice induced by adriamycin (ADR, 10 mg/kg) via a single tail vein. The protective effect of XBJ and its bioactive components on podocytes was demonstrated using mouse podocytes (MPC-5) induced by lipopolysaccharide (LPS, 4 μg/mL)...
April 1, 2024: European Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/38556066/modeling-the-complexity-of-drug-drug-interactions-a-physiologically-based-pharmacokinetic-study-of-lenvatinib-with-schisantherin-a-schisandrin-a
#30
JOURNAL ARTICLE
Aole Zheng, Dongsheng Yang, Chunyang Pan, Qingfeng He, Xiao Zhu, Xiaoqiang Xiang, Peiying Ji
BACKGROUND: Lenvatinib's efficacy as a frontline targeted therapy for radioactive iodine-refractory thyroid carcinoma and advanced hepatocellular carcinoma owes to its inhibition of multiple tyrosine kinases. However, as a CYP3A4 substrate, lenvatinib bears susceptibility to pharmacokinetic modulation by co-administered agents. Schisantherin A (STA) and schisandrin A (SIA) - bioactive lignans abundant in the traditional Chinese medicinal Wuzhi Capsule - act as CYP3A4 inhibitors, engendering the potential for drug-drug interactions (DDIs) with lenvatinib...
March 29, 2024: European Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/38556065/medicinal-products-with-ph-dependent-solubility-a-problem-for-ba-be-assessment
#31
REVIEW
Henning Blume, Werner Weitschies
The ICH M13A draft bioequivalence guideline allows the exclusion of very low plasma profiles from the statistical evaluation in exceptional cases, i.e., if such phenomenon occurs due to non-compliance of subjects (not swallowing the product). Moreover, the draft ICH guideline requests additional bioequivalence studies for medicinal products with pH-dependent solubility after concomitant administration of gastric pH modifying preparations, e.g., proton pump inhibitors. Both regulations are scientifically sound, however, would need further specification...
March 29, 2024: European Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/38556064/age-related-pharmacokinetics-differences-were-observed-between-young-and-elderly-populations-of-a-novel-pde5-inhibitor-youkenafil-and-its-metabolite-m459
#32
JOURNAL ARTICLE
Yuhong Lin, Yao Long, Yaqin Wang, Lin Wang, Minhui Wang, Xiaocui Xia, Xinyan Chen, Yunzhe Huang, Pengfei Du, Jianbang Wu, Yuanwei Jia, Jie Shen
PURPOSE: Youkenafil is a novel oral selective PDE5 inhibitor for treating Erectile Dysfunction. This investigation assessed pharmacokinetics (PK), safety, and tolerability of youkenafil and its main metabolite (M459) after taking 100 mg youkenafil hydrochloride tablets in elderly and young subjects. METHODS: This Phase I, single-center, open-label, parallel-group, single-dose study was conducted on 24 individuals (12 elders and 12 youngsters). Each subject received a single oral 100 mg youkenafil hydrochloride tablets...
March 29, 2024: European Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/38554983/development-of-novel-pyrimidine-nucleoside-analogs-as-potential-anticancer-agents-synthesis-characterization-and-in-vitro-evaluation-against-pancreatic-cancer
#33
JOURNAL ARTICLE
Esther Frimpong, Raviteja Bulusu, Joy Okoro, Andriana Inkoom, Nkafu Ndemazie, Sherise Rogers, Xue Zhu, Bo Han, Edward Agyare
The present study proposed modification of 5-FU by conjugation with an acyl chloride and a 5-membered heterocyclic ring to improve its in-vitro cytotoxicity and metabolic stability. XYZ-I-71 and XYZ-I-73 were synthesized by introducing a tetrahydrofuran ring on 5-fluorocytosine (a precursor of 5-FU) and conjugation with octanoyl chloride and lauroyl chloride, respectively. The structure of the synthesized compounds was validated using NMR and micro-elemental analysis. The antiproliferative activity of the analogs was determined against MiaPaCa-2, PANC-1, and BxPC-3 pancreatic cancer cells...
March 28, 2024: European Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/38522769/are-all-measures-of-liver-kp-uu-a-function-of-f-h-as-determined-following-oral-dosing-or-have-we-made-a-critical-error-in-defining-hepatic-drug-clearance
#34
JOURNAL ARTICLE
L Z Benet, J K Sodhi
Here we present, utilizing universally accepted relationships for hepatic clearance at steady state, that for all models of hepatic elimination the ratio of unbound liver drug concentration to unbound systemic blood concentration, Kpuu , is a function of or related to the hepatic bioavailability for that drug, FH . According to the derivation for the well-stirred model, Kpuu can never exceed unity, can frequently be a function of hepatic blood flow, and is equivalent to the value of FH as determined following oral dosing...
March 22, 2024: European Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/38518998/the-challenge-of-downstream-processing-of-spray-dried-amorphous-solid-dispersions-into-minitablets-designed-for-the-paediatric-population-a-sustainable-product-development-approach
#35
JOURNAL ARTICLE
Anja Autzen Virtanen, Monika Myślińska, Anne Marie Healy, Eoin Power, Atif Madi, Mia Sivén
Poorly water-soluble drugs present a significant challenge in the development of oral solid dosage forms (OSDs). In formulation development the appropriate use of excipients to adjust solubility, and the choice of manufacturing method and pharmaceutical processes to obtain a dosage form to meet the needs of the patient group, is crucial. Preparing an amorphous solid dispersion (ASD) is a well-established method for solubility enhancement, and spray drying (SD) a common manufacturing method. However, the poor flowability of spray dried materials poses a significant challenge for downstream processing...
March 20, 2024: European Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/38508502/enabling-a-novel-solvent-method-on-albendazole-solid-dispersion-to-improve-the-in-vivo-bioavailability
#36
REVIEW
Ming-Jie Han, Zhiyang Zou
Albendazole, a vital medication endorsed by the World Health Organization for combating parasitic infections, encounters a challenge stemming from its low solubility, significantly impeding absorption and bioavailability. Albendazole has near-insolubility in most organic solvents, so the solid dispersions of albendazole were predominantly using the fusion method. However, the solvent method could offer the advantage of achieving molecular-level mixing homogeneity. In this investigation, we incorporated the pH adjustment to prepare albendazole solid dispersion using a solvent method, which utilizes trace amounts of HCl in methanol, yielding notably enhanced albendazole solubility...
March 18, 2024: European Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/38499113/pharmacokinetics-safety-and-tolerability-of-the-novel-tetrameric-gadolinium-based-mri-contrast-agent-gadoquatrane-in-healthy-chinese-and-japanese-men-two-randomized-dose-escalation-studies-including-concentration-qtc-modeling
#37
JOURNAL ARTICLE
Xuemei He, Shunji Matsuki, Kexin Li, Yubin Sui, Kumi Matsuno, Mengyuan Ren, Gabriele Sutter, Birte Maria Hofmann
PURPOSE: To investigate the pharmacokinetics, safety, and tolerability of the novel tetrameric high-relaxivity gadolinium-based contrast agent gadoquatrane in Japanese (Study 1) and Chinese men (Study 2). PARTICIPANTS AND METHODS: In two similarly designed single-center, randomized, single-blind, placebo-controlled, consecutive-cohort dose-escalation studies, healthy volunteers were randomly assigned to intravenous administration of gadoquatrane (0.01-0.1 mmol gadolinium/kg body weight) or placebo...
March 16, 2024: European Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/38499112/efficiency-of-single-pharmaceutical-surfactants-to-mimic-intestinal-biorelevant-media-solubilization-and-dissolution-of-etravirine-comparison-of-intrinsic-and-film-dissolution-models
#38
JOURNAL ARTICLE
Ayse Nur Oktay, James E Polli
We understand that quality control dissolution media may best anticipate in vivo product performance by mimicking in vivo media, but preferably involve at most a single pharmaceutical surfactant for routine laboratory use. The objective here was to estimate the concentrations of six pharmaceutical surfactants to mimic etravirine solubility and intrinsic dissolution rate, as well as dissolution rate from a film model, in each Fed State Simulated Intestinal Fluid Version 2 (FeSSIF-V2) and Fasted State Simulated Intestinal Fluid Version 2 (FaSSIF-V2)...
March 16, 2024: European Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/38490876/corrigendum-to-does-nonlinear-blood-brain-barrier-transport-matter-for-lower-morphine-dosing-strategies-european-journal-of-pharmaceutical-sciences-187-2023-106482
#39
Berfin Gülave, Divakar Budda, Mohammed Aa Saleh, Jg Coen van Hasselt, Elizabeth Cm de Lange
No abstract text is available yet for this article.
March 14, 2024: European Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/38490522/effects-of-omitting-titanium-dioxide-from-the-film-coating-of-a-pharmaceutical-tablet-an-industrial-case-study-of-attempting-to-comply-with-eu-regulation-2022-63
#40
JOURNAL ARTICLE
Dorián László Galata, Melinda Sinka Lázárné, Dorottya Kiss-Kovács, Gergő Fülöp, Barnabás Dávid, Botond Bogáti, Máté Ficzere, Orsolya Péterfi, Brigitta Nagy, György Marosi, Zsombor Kristóf Nagy
Recently, concerns have been raised about the safety of titanium dioxide (TiO2 ), a commonly used component of pharmaceutical film coatings. The European Union has recently prohibited the application of this material in the food industry, and it is anticipated that the same will happen in the pharmaceutical industry. For this reason, pharmaceutical manufacturers have to consider the possible impact of removing TiO2 from the film coating of tablets. In this paper, we present a case study of a commercially produced tablet where the film coating containing TiO2 was replaced with a coating using calcium carbonate (CaCO3 ) or with a transparent coating...
March 13, 2024: European Journal of Pharmaceutical Sciences
journal
journal
31514
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.